A Randomized, Open-label, Crossover Clinical Trial to Compare The Pharmacokinetics of A Pregabalin GLARS Tablet 150mg and Immediate Release Formulation After Multiple Dosing Under Fed Condition in Healthy Male Subjects
Latest Information Update: 18 Sep 2019
At a glance
- Drugs Pregabalin (Primary)
- Indications Epilepsy; Fibromyalgia; Generalised anxiety disorder; Pain
- Focus Pharmacokinetics
- Sponsors GL PharmTech
- 11 Nov 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
- 18 Jul 2012 New trial record